The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 28, 2017

Filed:

Mar. 14, 2012
Applicants:

Mattheus Cornelis DE Wilde, Doorwerth, NL;

Johannes Wilhelmus Christina Sijben, Wageningen, NL;

Patrick Joseph Gerardus Hendrikus Kamphuis, De Bilt, NL;

Robert Johan Joseph Hageman, Wageningen, NL;

Assignee:

N.V. Nutricia, Zoetermeer, NL;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7072 (2006.01); A61K 31/7056 (2006.01); A61K 31/14 (2006.01); A61K 31/202 (2006.01); A61K 31/7068 (2006.01); A61K 9/00 (2006.01); A61K 31/205 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/4415 (2006.01); A61K 31/519 (2006.01); A61K 31/685 (2006.01); A61K 31/714 (2006.01); A23D 7/00 (2006.01); A23D 7/005 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7056 (2013.01); A23D 7/003 (2013.01); A23D 7/0053 (2013.01); A23L 33/115 (2016.08); A23L 33/13 (2016.08); A61K 9/0095 (2013.01); A61K 31/14 (2013.01); A61K 31/202 (2013.01); A61K 31/205 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4415 (2013.01); A61K 31/519 (2013.01); A61K 31/685 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/714 (2013.01); A23V 2002/00 (2013.01);
Abstract

The invention relates to a composition comprising: i) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof; ii) a lipid fraction comprising at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA) and docosapentaenoic acid (22:5; DPA), or esters thereof, in which the lipid fraction comprises less than 2 weight % of □-linolenic acid (ALA), calculated on the weight of all fatty acids; iii) choline, or salts or esters thereof; for use in the prevention or treatment of neurotrauma, traumatic brain injury, cerebral palsy and spinal cord injury.


Find Patent Forward Citations

Loading…